Arvo Raises $20M Series A led by Kaszek, to Revolutionize Healthcare Payments in Brazil
Arvo raises $20M Series A led by Kaszek and Base10 Partners, with participation from Canary and K50 Ventures; to expand AI-powered healthcare payment solutions in Brazil.

Arvo, the Brazilian healthtech that combines artificial intelligence and data integration to optimize healthcare payments, has successfully raised $20 million in a Series A round. The funding was led by Kaszek and Base10 Partners, with participation from Canary and K50 Ventures, marking one of the largest early-stage investments in Brazil’s healthtech sector.
Founded in 2022, Arvo’s platform automates billing validation and procedure authorization using AI and machine learning, aiming to increase efficiency, transparency, and security in healthcare payment processes.
“This investment is a recognition that financial sustainability in supplementary healthcare is a societal challenge. Inefficiencies drain over R$40 billion annually—resources that could fund hundreds of thousands of consultations and hospitalizations. This funding reinforces that we are on the right path to transform the relationship between health plans and providers,” said Fabricio Valadão, CEO and co-founder of Arvo.

Arvo’s Rapid Growth and Industry Impact
In just a few years, Arvo has processed over R$130 billion in healthcare claims, growing its revenue and client base fourfold in the past 12 months. Its AI tools have boosted auditing and billing productivity by an average of 25% within six months of adoption, generating savings equivalent to funding 15 million specialized medical consultations or 1.5 million medium-complexity hospitalizations based on Brazil’s national cost averages in 2024.
“Our AI tools allow us to analyze claims at scale with high precision, identifying patterns beyond individual reviews. With this Series A, we aim to triple our AI investment to reach new levels of accuracy and redefine healthcare payment validation in Brazil,” explained Rafael Tinoco, CPO and co-founder of Arvo.
How the $20M Series A Will Be Used

Arvo plans to utilize the funds to:
- Expand operations across Brazil
- Strengthen healthcare transaction-processing infrastructure
- Launch new AI-powered products
- Hire additional data science and engineering talent
- Explore strategic acquisitions
The company aims to cover additional stages of the healthcare payment cycle and solidify its position as a key player in Brazil’s health infrastructure.
Leading Investors Support Arvo
The Series A round attracted top-tier investors from both Latin America and the U.S.:
- Kaszek: Latin America’s largest venture capital firm, managing over $2 billion and backing companies like Nubank, Wellhub, and Alice.
- Base10 Partners: Silicon Valley-based fund with $1.5 billion invested globally, portfolio includes Brex, Figma, and Notion.
- Canary and K50 Ventures: Early-stage investors supporting tech and impact-driven startups.
AI at the Core of Healthcare Innovation
Arvo’s AI-powered platform is reshaping how healthcare providers and payers interact, increasing billing efficiency, reducing errors, and enhancing transparency. With this Series A, Arvo is set to accelerate growth, expand platform capabilities, and play a transformative role in Brazil’s healthcare payment ecosystem.